OKYO
Okyo Pharma·NASDAQ
--
--(--)
--
--(--)
3.79 / 10
Netural
Sentiment is neutral (3.79/10) but fund‑flow score is strong at 7.58, with overall inflow ratio 0.43 despite a negative trend. Small‑cap inflows are positive, while larger blocks are negative. Only one analyst issues a Buy, with no proven track record.
Fund Flow Rating
Analyst RatingBuy
Wall Street Opinions
Buy
Strong Buy
0%
Buy
100%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-02-20
InstitutionPiper Sandler
Times predicted1
Historical Win Rate0.0%
Is money flowing into or out of OKYO?
- OKYO holds a Bearish analyst rating, with 100% of experts assigning a Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 3.79/10 (Netural).
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
